# Stoke Therapeutics, Inc. (STOK) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Stoke Therapeutics, Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/STOK/mda/fy2025/): filed 2026-03-16; accession 0001193125-26-108362 (https://www.sec.gov/Archives/edgar/data/1623526/000119312526108362/stok-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/STOK/mda/fy2024/): filed 2025-03-18; accession 0000950170-25-041170 (https://www.sec.gov/Archives/edgar/data/1623526/000095017025041170/stok-20241231.htm)
- [FY 2023 MD&A](/company/STOK/mda/fy2023/): filed 2024-03-25; accession 0000950170-24-035912 (https://www.sec.gov/Archives/edgar/data/1623526/000095017024035912/stok-20231231.htm)
- [FY 2022 MD&A](/company/STOK/mda/fy2022/): filed 2023-03-06; accession 0001564590-23-003175 (https://www.sec.gov/Archives/edgar/data/1623526/000156459023003175/stok-10k_20221231.htm)
- [FY 2021 MD&A](/company/STOK/mda/fy2021/): filed 2022-03-10; accession 0001564590-22-009634 (https://www.sec.gov/Archives/edgar/data/1623526/000156459022009634/stok-10k_20211231.htm)

Back to /company/STOK/